Yüklüyor......
The association between BMI and BSA–temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525
BACKGROUND: Fearing increased myelotoxicity, many practitioners adjust the body surface area (BSA)-calculated doses in obese patients. Regarding temozolomide (TMZ), a prior study suggested men with a BSA >2 m(2) may experience increased toxicity; however, surprisingly, the inverse observation was...
Kaydedildi:
| Yayımlandı: | Neurooncol Pract |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899045/ https://ncbi.nlm.nih.gov/pubmed/31832217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|